Oncolytics Biotech, Inc. (ONCY)
0.4981
-0.05
(-9.04%)
USD |
NASDAQ |
Oct 16, 16:00
0.4978
0.00 (0.00%)
After-Hours: 20:00
Oncolytics Biotech Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | -0.006M |
| December 31, 2025 | -0.0009M |
| September 30, 2025 | -0.0041M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -0.0009M |
| September 30, 2024 | -0.0236M |
| June 30, 2024 | -0.112M |
| March 31, 2024 | -0.034M |
| December 31, 2023 | -0.0022M |
| September 30, 2023 | 5.044M |
| June 30, 2023 | 5.056M |
| March 31, 2023 | 4.931M |
| December 31, 2022 | -14.99M |
| September 30, 2022 | -0.0066M |
| June 30, 2022 | -0.0091M |
| March 31, 2022 | -0.028M |
| December 31, 2021 | -0.0593M |
| September 30, 2021 | -0.1624M |
| June 30, 2021 | -0.0054M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -0.0117M |
| June 30, 2020 | -0.0022M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.008M |
| December 31, 2019 | -0.0009M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.0052M |
| March 31, 2019 | -0.0021M |
| December 31, 2018 | 0.0096M |
| September 30, 2018 | -0.0307M |
| June 30, 2018 | -0.029M |
| March 31, 2018 | -0.0337M |
| December 31, 2017 | -0.0082M |
| September 30, 2017 | -0.0075M |
| June 30, 2017 | -0.0595M |
| March 31, 2017 | 1.574M |
| December 31, 2016 | -0.0097M |
| September 30, 2016 | -0.0037M |
| June 30, 2016 | -0.0044M |
| March 31, 2016 | -0.0203M |
| December 31, 2015 | -0.0457M |
| September 30, 2015 | -0.0135M |
| June 30, 2015 | -0.0144M |
| March 31, 2015 | -0.0332M |
| December 31, 2014 | -0.0192M |
| September 30, 2014 | -0.1045M |
| June 30, 2014 | -0.0011M |
| March 31, 2014 | -0.0417M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -1.659B |
| Arrowhead Pharmaceuticals, Inc. | 43.68M |
| Sangamo Therapeutics, Inc. | -0.013M |
| Sarepta Therapeutics, Inc. | -93.37M |
| Anixa Biosciences, Inc. | -0.245M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.066M |
| Cash from Financing (Quarterly) | 6.704M |
| Free Cash Flow | -26.53M |
| Free Cash Flow Per Share (Quarterly) | -0.0674 |
| Free Cash Flow to Equity (Quarterly) | -8.006M |
| Free Cash Flow to Firm (Quarterly) | -8.066M |
| Free Cash Flow Yield | -48.27% |